About this trial
The goal of this clinical trial is to evaluate the effectiveness of a digital psychoeducational intervention, "What Were We Thinking" (WWWT), to prevent the development of postpartum depression and anxiety symptoms in first-time mothers in Chile. The study includes adult women with a healthy, full-term infant younger than two months who are receiving care in primary health centers.
The main questions it aims to answer are:
* Does participation in the WWWT intervention reduce depressive and anxiety symptoms at 3 months after the end of the intervention compared to usual care? * Does participation in the intervention improve maternal self-efficacy, perceived social support, and coparenting relationship quality compared to usual care? Researchers will compare an experimental group receiving the full WWWT intervention with a control group receiving usual care to determine the effectiveness of the intervention.
Participants will:
* Complete self-report questionnaires assessing depressive symptoms, anxiety symptoms, maternal self-efficacy, perceived social support, and coparenting at baseline and at 3-month follow-up * Be randomly assigned to either the intervention group or the control group * Receive the WWWT intervention between 4 and 10 weeks postpartum (intervention group), including:
* Fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks * Individual contact with a trained facilitator through text messaging * One virtual group session with other mothers and a facilitator * Continue receiving usual care in primary health services (control group) and receive a shortened version of the intervention after the follow-up assessment
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
First-time mothers (primiparous women)
Aged 18 years or older
Having a healthy, full-term infant younger than 2 months of age
Receiving prenatal or postnatal care at participating primary health centers in Chile
Disqualifiers
Severe symptoms of depression or anxiety at baseline requiring immediate specialized mental health treatment
Severe psychosocial problems (e.g., substance abuse, domestic violence, significant cognitive impairment)
Infant born preterm or with severe medical conditions (e.g., genetic disorders or serious neonatal complications)
Inability to provide informed consent or participate in study procedures due to language or cognitive barriers
Trial design
Parallel
Treatments tested in this trial
What Were We Thinking (WWWT) mHealth Intervention
BehavioralThe "What Were We Thinking" (WWWT) is a psychoeducational, preventive mHealth intervention designed for first-time mothers to reduce the risk of postpartum depression and anxiety. The intervention targets modifiable risk factors, including maternal self-efficacy in infant care and perceived social support. It is delivered between 4 and 10 weeks postpartum and includes three components: (1) fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks, accompanied by reflective prompts; (2) asynchronous support from a trained facilitator via text messaging; and (3) one virtual group session led by the facilitator. Facilitators are trained health professionals and can refer participants to primary care services when needed.
Treatment groups
Trial outcomes
Primary outcomes
Postpartum depressive symptoms
Depressive symptoms assessed using the Edinburgh Postnatal Depression Scale (EPDS)
Postpartum anxiety symptoms
Anxiety symptoms assessed using the Depression, Anxiety and Stress Scales (DASS-21)
Secondary outcomes
Maternal self-efficacy
Maternal self-efficacy assessed using the Escala de Evaluación Parental (EEP)
Perceived social support
Perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS)
Satisfaction with coparenting
Satisfaction with coparenting assessed using the Escala de Evaluación Parental (EEP)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidad del Desarrollo
Lead sponsor
University of Barcelona
Collaborator
This trial is not recruiting at the moment. You can still explore other options: